Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix

Experimental Oncology

Volumn 27, Issue 4, 2005, Pages 308-313

  Markeeva, N ^a   Lysovskiy, I ^a   Zhuravel, E ^a   Soldatkina, M ^a   Lyzogubov, V ^a,b   Usenko, V ^b   Potapov, V ^c   Pogrebnoy, P ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b Morphological Laboratory BIONTEC   (Ukraine)

^c Dnipropetrovsk State Medical Academy   (Ukraine)

Author keywords

Cervical cancer; Human beta defensin 2; Immunohistochemical analysis; Proliferation

Indexed keywords

BETA DEFENSIN 2; CYCLINE; MONOCLONAL ANTIBODY; THYMIDINE; TRITIUM;

ADENOCARCINOMA; ARTICLE; CELL PROLIFERATION; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; UTERINE CERVIX CARCINOMA;

BETA-DEFENSINS; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; PROLIFERATING CELL NUCLEAR ANTIGEN; RECOMBINANT PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 31344478753     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Yang D, Biragyn A, Kwak LW, Oppenheim JJ. Mammalian defensins in immunity: more than just microbicidal. Trends Imunol 2002; 23: 291-6.
2. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-20.
3. Kamysz W, Okroj M, Lukasiak J. Novel properties of antimicrobial peptides. Acta Biochim Polonica 2003; 50: 461-9.
4. Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe KF, Litvinov SV, van Krieken JH, de Boer WI, Hiemstra PS. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 2002; 72: 167-74.
5. Muller CA, Markovic-Lipkovski J, Klatt T, Gamper J, Schwarz G, Beck H, Deeg M, Kalbacher H, Widmann S, Wessels JT, Becker V, Muller GA, Flad T. Human alpha-defensins HNPs-1, -2, and -3 in renal cell carcinoma: influences on tumor cell proliferation. Am J Pathol 2002; 160: 1311-24.
6. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sorensen OE, Borregaard N, Rabe KF, Hiemstra PS. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003; 171: 6690-6.
7. Meyer JE, Harder J, Gorogh T, Weise JB, Schubert S, Janssen D, Maune S. Human beta-defensin-2 in oral cancer with opportunistic Candida infection. Anticancer Res 2004; 24: 1025-30.
8. Yoshimoto T, Yamaai T, Mizukawa N, Sawaki K, Nakano M, Yamachika E, Sugahara T. Different expression patterns of beta-defensins in human squamous cell carcinomas. Anticancer Res 2003; 23: 4629-33.
9. Melle C, Ernst G, Schimmel B, Bleui A, Thieme H, Kaufmann R, Mothes H, Settmacher U, Claussen U, Halbhuber KJ, Von Eggeling F. Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer. Gastroenterology 2005; 129: 66-73.
10. Shnitsar VM, Lisovskiy IL, Soldatkina MA, Nespryadko SV, Turchak OV, Vinnitskaya AB, Pogrebniy PV. Human beta-defensin 3 (hBD-3) expression in A431 cell line and human vulval tumors. Exp Oncol 2004; 26: 328-30.
11. Lisovskiy IL, Soldatkina MA, Lytvyn DI, Markeeva NV, Turchak OV, Nespryad'ko SV, Vinnitskaya AB, Nosach LN, Povnitsa OU, Pogrebnoy PV. Pattern of beta-defensin-2 and EGFR mRNAs expression in cervical and vulval cancer cells. Exp Oncol 2001; 23: 248-52.
12. Schuetz AN, Yin-Goen Q, Amin MB, Moreno CS, Cohen C, Hornsby CD, Yang WL, Petros JA, Issa MM, Pattaras JG, Ogan K, Marshall FF, Young AN. Molecular classification of renal tumors by gene expression profiling. J Mol Diagn 2005;7:206-18.
13. Albrethsen J, Bogebo R, Gammeltoft S, Olsen J, Winther B, Raskov H. Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer 2005; 5: 8.
14. Nam MJ, Kee MK, Kuick R, Hanash SM. Identification of defensin alpha6 as a potential biomarker in colon adenocarcinoma. J Biol Chem 2005; 280: 8260-5.
15. Arimura Y, Ashitani J, Yanagi S, Tokojima M, Abe K, Mukae H, Nakazato M. Elevated serum beta-defensins concentrations in patients with lung cancer. Anticancer Res 2004; 24: 4051-7.
16. Conejo-Garcia JR, Benencia F, Courreges MC, Kang E, Mohamed-Hadley A, Buckanovich RJ, Holtz DO, Jenkins A, Na H, Zhang L, Wagner DS, Katsaros D, Caroll R, Coukos G. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat Med 2004; 10: 950-8.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63.
18. Markeeva N, Lisovskiy I, Lyzogubov V, Usehko V, Soldatkina M, Merentsev S, Zaitsev S, Kondratskii Yu, Tofan A, Osinskiy S, Pogrebnoy P. Expression of beta-defensin-2 in human gastric tumors: a pilot study. Exp Oncol 2005; 27:130-5.
19. Pogribnoy PV, Lisovskiy IL, Markeeva NV, Shnitsar VM, Zinchenko H, Soldatkina MA. Production of recombinant of hBD-2 -human antimicrobial peptide expressed in cervical and vulval cancer. Exp Oncol 2003; 25: 36-9.